Skip to main content
Steven Coca, DO, Nephrology, New York, NY

StevenGCocaDOMS

Nephrology New York, NY

Associate Professor, Internal Medicine, Icahn School of Medicine at Mount Sinai

Dr. Coca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Coca's full profile

Already have an account?

  • Office

    Icahn School of Medicine at Mount Sinai
    New York, NY 10029
    Phone+1 212-241-6633

Education & Training

  • Yale graduate school of arts and sciences
    Yale graduate school of arts and sciencesMS, Epidemiology and Public Health , 2006 - 2008
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Nephrology, 2004 - 2008
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2004
  • University of New England College of Osteopathic Medicine
    University of New England College of Osteopathic MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State License 2014 - 2026
  • CT State Medical License
    CT State License 2005 - 2015

Publications & Presentations

PubMed

Journal Articles

  • National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions  
    Steven Coca, DO, American Journal of Nephrology

Press Mentions

  • Screening to Predict Development of Kidney Disease Underutilized, Doctors Say
    Screening to Predict Development of Kidney Disease Underutilized, Doctors SayJune 24th, 2022
  • KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
    KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient CohortJune 6th, 2022
  • XORTX Therapeutics : Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients - Form 6-K
    XORTX Therapeutics : Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients - Form 6-KDecember 10th, 2021
  • Join now to see all

Grant Support

  • Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers”NIDDK2015–2020
  • Novel serum and urinary Biomarkers of Diabetic Kidney DiseaseNIDDK2012–2017
  • Long-Term Prognosis Of Acute Kidney Injury In Cardiac SurgeryNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
  • Urinary Biomarkers For Acute Kidney Injury In Critical IllnessNational Institute Of Diabetes And Digestive And Kidney Diseases2007